Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002573257 | SCV003617440 | pathogenic | Inborn genetic diseases | 2022-06-16 | criteria provided, single submitter | clinical testing | The c.335delC (p.P112Rfs*8) alteration, located in exon 5 (coding exon 5) of the B3GLCT gene, consists of a deletion of one nucleotide at position 335, causing a translational frameshift with a predicted alternate stop codon after 8 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |
Genome Diagnostics Laboratory, |
RCV001579971 | SCV001809236 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579971 | SCV001963793 | pathogenic | not provided | no assertion criteria provided | clinical testing |